--2025/Q1-- / 0.000--
--2024/Q4-- / 1.192M--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q16.440M / 3.238M--
Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
LVTX LAVA Therapeutics
- 1.110
- -0.090-7.50%
Close Dec 13 16:00 ET
- 1.140
- +0.030+2.70%
Post 20:01 ET
29.19MMarket Cap-1.10P/E (TTM)
1.200High1.080Low157.49KVolume1.200Open1.200Pre Close178.24KTurnover1.30%Turnover RatioLossP/E (Static)26.30MShares6.47052wk High0.88P/B13.42MFloat Cap1.08052wk Low--Dividend TTM12.09MShs Float17.200Historical High--Div YieldTTM10.00%Amplitude1.080Historical Low1.131Avg Price1Lot Size
LAVA Therapeutics Key Stats
LAVA Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: EUR
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
LAVA Therapeutics Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data